PG2 Treatment Among Stage II/III Breast Cancer Patients Receiving Adjuvant Chemotherapy

NCT03314805 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

67

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer-related Fatigue
Neutropenia, Malignant

Interventions

DRUG: Astragalus polysaccharides 500 mg
DRUG: Placebo
PROCEDURE: EC Chemotherapy

Sponsor

PhytoHealth Corporation